[1] Serbina NV, Jia T, Hohl TM, et al. Monocyte-mediated defense against microbial pathogens[J]. Annu Rev Immuno, 2008, 26(4):21-52.
[2] Shi C, Pamer EG. Monocyte recruitment during infection and inflammation[J]. Nat Rev Immunol, 2011, 11(11):762-774.
[3] Soudja SM, Ruiz AL, Marie JC, et al. Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion[J]. Immunity, 2012, 37(3):549-562.
[4] Xiong H, Keith JW, Samilo DW, et al. Innate Lymphocyte/Ly6C(hi) Monocyte Crosstalk Promotes Klebsiella Pneumoniae Clearance[J]. Cell, 2016, 165(3):679-689.
[5] Majer O, Bourgeois C, Zwolanek F, et al. Type I Interferons Promote Fatal Immunopathology by Regulating Inflammatory Monocytes and Neutrophils during Candida Infections[J]. PLoS Pathog, 2012, 8(7):1002811.
[6] Italiani P, Boraschi D. From Monocytes to M1/M2 Macrophages:Phenotypical vs. Functional Differentiation[J]. Front Immunol, 2014, 5(5):14.
[7] Anbazhagan K, Duroux-Richard I, Jorgensen C, et al. Transcriptomic network support distinct roles of classical and non-classical monocytes in human[J]. Int Rev Immunol, 2014, 33(6):470-489.
[8] Stansfield BK, Ingram DA. Clinical significance of monocyte heterogeneity[J]. Clin Transl Med, 2015, 4:5.
[9] Ingersoll MA, Spanbroek R, Lottaz C, et al. Comparison of gene expression profiles between human and mouse monocyte subsets[J]. Blood, 2010, 115(3):10-19.
[10] Hanna RN, Caelin LM, Hubbeling HG, et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes[J]. Nat Immunol, 2011, 12(8):778-785.
[11] Rachael LT,Stephen DM. Molecular control of monocyte development[J]. Cell Immunol,2014, 291(0):16-21.
[12] Wong KL, Tai JJ, Wong WC, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets[J]. Blood, 2011, 118(5):16-31.
[13] Shantsila E, Wrigley B, Tapp L, et al. Immunophenotypic characterization of human monocyte subsets:possible implications for cardiovascular disease pathophysiology[J]. Thromb Haemost,2011, 9(5):1056-1066.
[14] Pettit AC, Kropsli JA, Castilho JL, et al. The index case for the fungal meningitis outbreak in the United States[J]. N Engl J Med, 2012, 367(22):2119-2125.
[15] Hettinger J, Richards DM, Hansson J, et al. Origin of monocytes and macrophages in a committed progenitor[J]. Nat Immunol, 2013, 14(8):821-830.
[16] Thomas G, Tacke R, Hedrick CC, et al. Nonclassical patrolling monocyte function in the vasculature.[J]. Arterioscler Thromb Vasc Biol, 2015, 35(6):1306-1316.
[17] Ngo LY, Kasahara S, Kumasaka DK, et al. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis[J]. J Infect Dis, 2014, 209(1):109-119.
[18] Lionakis MS, Swamydas M, Fischer BG, et al. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival[J]. J Clin Invest, 2013, 123(12):5035-5051.
[19] Smeekens SP, van de Veerdonk FL, Joosten LA, et al. The classical CD14(+)(+) CD16(-) monocytes, but not the patrolling CD14(+) CD16(+) monocytes, promote Th17 responses to Candida albicans[J]. Eur J Immunol, 2011, 41(10):2915-2924.
[20] Domínguez-Andrés J, Feo-Lucas L, Minguito de la Escalera M, et al. Inflammatory Ly6Chigh Monocytes Protect against Candidiasis through IL-15-Driven NK Cell/Neutrophil Activation[J]. Immunity, 2017, 46(6):1059-1072.e4.
[21] Naranbhai V, Chang CC, Durgiah R, et al. Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection[J]. AIDS, 2014, 28(5):657-666.
[22] Serbina NV, Cherny M, Shi C, et al. Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia[J]. J Immunol, 2009, 183(4):2678-2687.
[23] Espinosa V, Jhingran A, Dutta O, et al. Inflammatory monocytes orchestrate innate antifungal immunity in the lung[J].PLoS Pathog, 2014, 10(2):e1003940.
[24] Venturini J, Cavalcante RS, Golim Mde A, et al. Phenotypic and functional evaluations of peripheral blood monocytes from chronic-form paracoccidioidomycosis patients before and after treatment[J]. BMC Infect Dis, 2014, 14(5):52. |